Page last updated: 2024-08-23

paroxetine and Dizziness

paroxetine has been researched along with Dizziness in 20 studies

Research

Studies (20)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	10 (50.00)	18.2507
2000's	7 (35.00)	29.6817
2010's	3 (15.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carson-Chahhoud, KV; Pollok, J; van Agteren, JE	1
Preskorn, SH	1
Hata, H; Kitagawa, Y; Kitamori, S; Onodera, M; Yamazaki, Y	1
Kaneko, S; Yasui-Furukori, N	1
Finfgeld, DL	1
Horii, A; Kitahara, T; Kubo, T; Mitani, K; Takeda, N; Uno, A	1
Carlson, NE; Chung, KA; Nutt, JG	1
Dobkin, RD; Marin, H; Menza, MA	1
Aviv, A; Barak, Y; Mazeh, D; Shahal, B; Zemishlani, H	1
Muniz Piniella, P; Relleke, M; van den Tweel, ER	1
Debattista, C; Schatzberg, AF	1
Pyke, RE	1
Buttolph, ML; Cyr, P; Jenike, MA; Keuthen, NJ; Minichiello, WE; Ricciardi, JA	1
Bell, CJ; Coupland, NJ; Potokar, JP	1
Haddad, P	1
Mitchell, S; Tracy, KA; Zajecka, J	1
Schechter, JO	1
Brøsen, K; Skjelbo, EF	1
Pollock, BG	1
Beringer, TR; Kelly, RE; Robinson, H	1

Reviews

3 review(s) available for paroxetine and Dizziness

Article	Year
Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease. The Cochrane database of systematic reviews, 2018, 12-19, Volume: 12 Topics: Antidepressive Agents, Tricyclic; Depression; Dizziness; Dyspnea; Exercise Tolerance; Forced Expiratory Volume; Humans; Nausea; Nortriptyline; Paroxetine; Placebos; Pulmonary Disease, Chronic Obstructive; Quality of Life; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline	2018
Newer antidepressants and the discontinuation syndrome. The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 7 Topics: Adverse Drug Reaction Reporting Systems; Cyclohexanols; Dizziness; Fluoxetine; Headache; Humans; Incidence; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride	1997
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review. The Journal of clinical psychiatry, 1997, Volume: 58, Issue:7 Topics: 1-Naphthylamine; Adolescent; Adult; Child; Clinical Trials as Topic; Cyclohexanols; Dizziness; Female; Fluoxetine; Fluvoxamine; Headache; Humans; Infant; Infant, Newborn; Male; MEDLINE; Mental Disorders; Middle Aged; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride	1997

Trials

5 trial(s) available for paroxetine and Dizziness

Article	Year
An open-label, noncomparative, dose escalation pilot study of the effect of paroxetine in treatment of burning mouth syndrome. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2009, Volume: 107, Issue:1 Topics: Adult; Aged; Burning Mouth Syndrome; Dizziness; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Nausea; Paroxetine; Pilot Projects; Prospective Studies; Selective Serotonin Reuptake Inhibitors	2009
Short-term paroxetine treatment does not alter the motor response to levodopa in PD. Neurology, 2005, May-24, Volume: 64, Issue:10 Topics: Accidental Falls; Aged; Brain; Cross-Over Studies; Dizziness; Dopamine; Dopamine Agents; Double-Blind Method; Drug Interactions; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Paroxetine; Presynaptic Terminals; Selective Serotonin Reuptake Inhibitors; Serotonin; Treatment Failure; Vestibular Diseases	2005
An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2 Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Bupropion; Dizziness; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Headache; Humans; Male; Middle Aged; Nausea; Paroxetine; Pilot Projects; Piperazines; Quality of Life; Quinolones; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2007
A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression. International clinical psychopharmacology, 2007, Volume: 22, Issue:6 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Diagnostic and Statistical Manual of Mental Disorders; Dizziness; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Male; Nausea; Paroxetine; Psychiatric Status Rating Scales; Remission Induction; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia	2007
Paroxetine oral solution is bioequivalent to paroxetine tablets--advantages of the solution. International journal of clinical pharmacology and therapeutics, 2007, Volume: 45, Issue:11 Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Cross-Over Studies; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Half-Life; Headache; Humans; Male; Mesylates; Middle Aged; Nausea; Paroxetine; Pharmaceutical Solutions; Selective Serotonin Reuptake Inhibitors; Tablets; Therapeutic Equivalency; Vomiting	2007

Other Studies

12 other study(ies) available for paroxetine and Dizziness

Article	Year
Complexities of personalized medicine: how genes, drug-drug interactions, dosing schedules, and other factors can combine to produce clinically meaningful differences in a drug's effect. Journal of psychiatric practice, 2013, Volume: 19, Issue:5 Topics: Affective Disorders, Psychotic; Aged; Antipsychotic Agents; Depressive Disorder, Major; Dizziness; Drug Interactions; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Isoxazoles; Male; Paroxetine; Pharmacogenetics; Piperidines; Precision Medicine	2013
Hallucination induced by paroxetine discontinuation in patients with major depressive disorders. Psychiatry and clinical neurosciences, 2011, Volume: 65, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Dizziness; Female; Hallucinations; Headache; Humans; Nausea; Paroxetine; Substance Withdrawal Syndrome	2011
Selective serotonin reuptake inhibitor. Discontinuation syndrome. Journal of psychosocial nursing and mental health services, 2002, Volume: 40, Issue:12 Topics: Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder; Dizziness; Drug Administration Schedule; Humans; Male; Nurse Practitioners; Paroxetine; Patient Education as Topic; Psychiatric Nursing; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Treatment Refusal	2002
Paroxetine, a selective serotonin reuptake inhibitor, reduces depressive symptoms and subjective handicaps in patients with dizziness. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2004, Volume: 25, Issue:4 Topics: Activities of Daily Living; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Depression; Dizziness; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Treatment Outcome	2004
Physical symptoms associated with paroxetine withdrawal. The American journal of psychiatry, 1995, Volume: 152, Issue:8 Topics: Adult; Depressive Disorder; Dizziness; Ejaculation; Fatigue; Humans; Male; Middle Aged; Nausea; Paroxetine; Substance Withdrawal Syndrome; Tremor	1995
Paroxetine withdrawal syndrome. The American journal of psychiatry, 1995, Volume: 152, Issue:1 Topics: Adult; Anorexia; Anxiety Disorders; Depressive Disorder; Diarrhea; Dizziness; Female; Humans; Nausea; Paroxetine; Substance Withdrawal Syndrome	1995
Medication withdrawal symptoms in obsessive-compulsive disorder patients treated with paroxetine. Journal of clinical psychopharmacology, 1994, Volume: 14, Issue:3 Topics: Adult; Dizziness; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Substance Withdrawal Syndrome	1994
Serotonin reuptake inhibitor withdrawal. Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:5 Topics: 1-Naphthylamine; Adolescent; Adult; Age Factors; Clomipramine; Dizziness; Female; Fluvoxamine; Humans; Male; Middle Aged; Paresthesia; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Substance Withdrawal Syndrome	1996
Treatment of disequilibrium and nausea in the SRI discontinuation syndrome. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:8 Topics: Ataxia; Dizziness; Female; Humans; Nausea; Paroxetine; Phytotherapy; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Zingiberales	1998
[Interaction between paroxetine and clomipramine as a possible reason for admission to a department of internal medicine]. Ugeskrift for laeger, 1998, Sep-21, Volume: 160, Issue:39 Topics: Aged; Antidepressive Agents, Tricyclic; Clomipramine; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dizziness; Drug Interactions; Female; Genotype; Hospitalization; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors	1998
Discontinuation symptoms and SSRIs. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:10 Topics: Biological Availability; Depressive Disorder; Dizziness; Fluoxetine; Follow-Up Studies; Half-Life; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	1998
Hyponatremia in an older patient. Journal of the American Geriatrics Society, 1999, Volume: 47, Issue:8 Topics: Aged; Antidepressive Agents, Second-Generation; Confusion; Dizziness; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sodium	1999